Percutaneous transluminal angioplasty (PTA) is a technique in which a small flexible catheter with very low diameter of few millimeters is inserted into an artery and is guided to a desired location where the blood vessel has been narrowed down owing to some form of cardiovascular disease. Upon reaching the desired location, a small balloon is inflated at the end of the catheter, thereby compressing the blocking factor responsible for narrow artery against the blood vessel wall, thereby restoring the normal blood flow. The inflation of the balloon results in widening of the blood vessel opening and increasing the blood flow to the heart. Often a stent is placed during the procedure, in order to keep the artery open after the balloon is deflated and removed.

Superior technological improvements such as progressive flexibility due to innovations in hydrophilic design, superior hydrophilic coatings, enhanced performance under high pressure owing to added pushability, and robust design reducing friction are likely to fuel the growth of the global percutaneous transluminal angioplasty balloons market during the forecast period. Increasing population affected by cardiovascular diseases owing to life-style related diseases such as obesity, and rising reimbursement coverage for the treatment of cardiac diseases especially among end-users in developing countries (which have relatively higher patient population) are some of the factors likely to drive the growth of the global percutaneous transluminal angioplasty balloons market during 2017-2025. However, risk of patient discomfort during inflation of the balloon, and probability of restenosis are some of the factors likely to restrain the growth of the global percutaneous transluminal angioplasty balloons market during the forecast period.

The global percutaneous transluminal angioplasty balloons market can be segmented based on product type, over-the-wire guidewire compatibility, end-user, disease type, and region. Based on product type, the global percutaneous transluminal angioplasty balloons market has been bifurcated into cutting and scoring balloons, and drug eluting balloons. On the basis of over-the-wire guidewire compatibility (in inches), the global percutaneous transluminal angioplasty balloons market can be segmented in terms of 0.035”, 0.018”, and 0.014”. In terms of end-user, the global percutaneous transluminal angioplasty balloons market can been categorized into hospitals, ambulatory surgical centers, and specialty clinics.

In terms of regions, the global percutaneous transluminal angioplasty balloons market can be classified into five geographies: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to hold major share of the global percutaneous transluminal angioplasty balloons market, in terms of value, during the forecast period. This is mainly attributed to greater adoption of newly introduced minimally invasive percutaneous transluminal angioplasty balloons among physicians, significant reimbursement coverage, and growth in the incidence of cardiovascular diseases caused by lifestyle-related diseases such as obesity. However, the global percutaneous transluminal angioplasty balloons market in Asia Pacific is forecast to expand at a comparatively higher growth rate during the forecast period, in terms of revenue, due to the significant patient population experiencing cardiovascular diseases, rising market penetration by local manufacturers, and relatively lower market entry barriers in this high development potential region for established market players who aim at strengthening their geographical presence.

Angioplasty procedures are relatively easy when compared to bypass surgeries. However, the incidence of restenosis limits the application of these procedures. Future growth opportunities lie in the development of robust designs that overcome this drawback. Many emerging market players are involved in the development of drug eluting balloons such as heparin, paclitaxel, etc. that help in the prevention of re-occurrence of arterial blockage. Key players operating in the global percutaneous transluminal angioplasty balloons market are Medtronic, (Terumo Cardiovascular Systems Corporation) Terumo Corporation, ENDOCOR GmbH, Abbott, Cardinal Health, Boston Scientific Corporation, AngioDynamics, (Spectranetics) Koninklijke Philips N.V., iVascular S.L.U, and eucatech AG, among others.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Percutaneous Transluminal Angioplasty Balloons Market

Pre Book